The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 01, 2020

Filed:

Jul. 22, 2015
Applicant:

Orum Therapeutics Inc., Daejeon, KR;

Inventors:

Yong-Sung Kim, Gyeonggi-do, KR;

Dong-Ki Choi, Gyeonggi-do, KR;

Seung-Min Shin, Seoul, KR;

Sung-Hoon Kim, Seoul, KR;

Assignee:

ORUM THERAPEUTICS INC., Daejeon, KR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/32 (2006.01); C07K 16/40 (2006.01); C07K 16/42 (2006.01); A61K 39/00 (2006.01); C07K 17/08 (2006.01); G01N 33/566 (2006.01); C07K 16/44 (2006.01); G01N 33/574 (2006.01); C07K 7/06 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C07K 16/40 (2013.01); C07K 7/06 (2013.01); C07K 16/32 (2013.01); C07K 16/44 (2013.01); C12Y 306/05002 (2013.01); G01N 33/566 (2013.01); G01N 33/5748 (2013.01); G01N 33/6854 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/30 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/569 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); C07K 2317/77 (2013.01); C07K 2317/92 (2013.01); C07K 2319/00 (2013.01); G01N 2333/914 (2013.01); G01N 2500/04 (2013.01);
Abstract

The present disclosure relates to a method for inhibiting intracellular activated (GTP-bound) RAS using an intact immunoglobulin-type antibody having the ability to penetrate the cytosol, and to the use thereof. The disclosure further relates to a heavy-chain variable region (VH) which induces an intact immunoglobulin-type antibody to penetrate the cytosol and bind to activated RAS in the cytosol, and to an antibody comprising the same. The disclosure correspondingly provides a method for inhibiting the growth of cancer or tumor cells using the antibody, and a method for treating cancer or tumor.


Find Patent Forward Citations

Loading…